ADRENOCORTICAL CARCINOMA

ADRENOCORTICAL CARCINOMA was reported 88 times

These drug classes are most commonly taken by patients reporting ADRENOCORTICAL CARCINOMA:

# Drug Count
0 Platinum-based Drug [EPC] 25
1 Topoisomerase Inhibitor [EPC] 21
2 Folate Analog Metabolic Inhibitor [EPC] 13
3 Corticosteroid [EPC] 9
4 Dihydropyridine Calcium Channel Blocker [EPC] 9
5 Calcium Channel Blocker [EPC] 8
6 Angiotensin Converting Enzyme Inhibitor [EPC] 7
7 Kinase Inhibitor [EPC] 6
8 Nucleoside Metabolic Inhibitor [EPC] 6
9 Loop Diuretic [EPC] 5
10 Thiazide Diuretic [EPC] 5
11 Tumor Necrosis Factor Blocker [EPC] 5
12 Leukocyte Growth Factor [EPC] 4
13 Azole Antifungal [EPC] 3
14 Benzodiazepine [EPC] 3
15 Insulin Analog [EPC] 3
16 Interferon beta [EPC] 3
17 Progestin Antagonist [EPC] 3
18 Aldosterone Antagonist [EPC] 2
19 Alkylating Drug [EPC] 2
20 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 2
21 Factor Xa Inhibitor [EPC] 2
22 Osmotic Laxative [EPC] 2
23 Programmed Death Receptor-1 Blocking Antibody [EPC] 2
24 Sulfonamide Antimicrobial [EPC] 2
25 Sulfonylurea [EPC] 2
26 Vascular Endothelial Growth Factor Inhibitor [EPC] 2
27 Xanthine Oxidase Inhibitor [EPC] 2
28 alpha-Adrenergic Blocker [EPC] 2
29 beta-Adrenergic Blocker [EPC] 2
30 Adrenal Steroid Synthesis Inhibitor [EPC] 1
31 Angiotensin 2 Receptor Blocker [EPC] 1
32 Atypical Antipsychotic [EPC] 1
33 CD20-directed Cytolytic Antibody [EPC] 1
34 CD30-directed Immunoconjugate [EPC] 1
35 Calcineurin Inhibitor Immunosuppressant [EPC] 1
36 Central alpha-2 Adrenergic Agonist [EPC] 1
37 Expectorant [EPC] 1
38 GLP-1 Receptor Agonist [EPC] 1
39 HMG-CoA Reductase Inhibitor [EPC] 1
40 Histamine-2 Receptor Antagonist [EPC] 1
41 Interleukin-17A Antagonist [EPC] 1
42 Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] 1
43 Microtubule Inhibitor [EPC] 1
44 Nonsteroidal Anti-inflammatory Drug [EPC] 1
45 Opioid Agonist [EPC] 1
46 P2Y12 Platelet Inhibitor [EPC] 1
47 PCSK9 Inhibitor [EPC] 1
48 Phenothiazine [EPC] 1
49 Potassium Salt [EPC] 1
50 Proton Pump Inhibitor [EPC] 1
51 RANK Ligand Inhibitor [EPC] 1
52 Serotonin-3 Receptor Antagonist [EPC] 1
53 Thalidomide Analog [EPC] 1
54 mTOR Inhibitor Immunosuppressant [EPC] 1